Genetically Modified T Cells Against Ovarian Cancer
NCT03184753
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
BIOLOGICAL:
OC-IgT cells
Sponsor
Shenzhen Geno-Immune Medical Institute